【英特集团:英特药业以3.69亿元的价格成功竞得华通医药100%股权】英特集团(000411.SZ)公告称,公司全资子公司英特药业以3.69亿元的价格成功竞得浙江华通医药集团有限公司100%股权,并与转让方浙农股份签署了相关交易合同。本次交易尚需通过中国反垄断审查机构的经营者集中审查,交易完成后,华通医药将成为英特集团的全资子公司,有助于提升公司在浙江市场的医药批发及零售业务占有率。

金融界
Jun 03, 2025
英特集团(000411.SZ)公告称,公司全资子公司英特药业以3.69亿元的价格成功竞得浙江华通医药集团有限公司100%股权,并与转让方浙农股份签署了相关交易合同。本次交易尚需通过中国反垄断审查机构的经营者集中审查,交易完成后,华通医药将成为英特集团的全资子公司,有助于提升公司在浙江市场的医药批发及零售业务占有率。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10